About NANO MRNA
Corporate Philosophy
Corporate Profile
History
Access
Our business
Nucleic acid therapeutics business
Sales Business
Pipeline
mRNA medicine
Cancer vaccine
Local Tissue Regenerative Medicine
Genome Editing
NEWS
JP
Pipeline
Target Factor
Indication
Seed
Pre-Clinical
Phase I
Phase Ib
TUG1 ASO
GBM
Partner: Nagoya University
RUNX1 mRNA
Osteoarthritis
PrimRNA
*
Partner: Institute of Science Tokyo
*Subsidiary of NANO MRNA
NANO MRNA Co.,Ltd.
>
Pipeline